These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17634645)

  • 1. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy.
    Zheng Y; Newhauser W; Fontenot J; Taddei P; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4481-96. PubMed ID: 17634645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
    Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
    Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
    Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
    Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neutron dose equivalent from the Mevion S250 proton accelerator: measurements and calculations.
    Chen KL; Bloch CD; Hill PM; Klein EE
    Phys Med Biol; 2013 Dec; 58(24):8709-23. PubMed ID: 24301001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
    Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
    Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams.
    Zheng Y; Liu Y; Zeidan O; Schreuder AN; Keole S
    Med Phys; 2012 Jun; 39(6):3484-92. PubMed ID: 22755728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
    Polf JC; Newhauser WD
    Phys Med Biol; 2005 Aug; 50(16):3859-73. PubMed ID: 16077232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient neutron dose equivalent exposures outside of the proton therapy treatment field.
    Polf JC; Newhauser WD; Titt U
    Radiat Prot Dosimetry; 2005; 115(1-4):154-8. PubMed ID: 16381704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary neutron doses for several beam configurations for proton therapy.
    Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdosimetry distributions for 40-200 MeV protons.
    Palajová Z; Spurný F; Davídková M
    Radiat Prot Dosimetry; 2006; 121(4):376-81. PubMed ID: 16782987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configuration and validation of an analytical model predicting secondary neutron radiation in proton therapy using Monte Carlo simulations and experimental measurements.
    Farah J; Bonfrate A; De Marzi L; De Oliveira A; Delacroix S; Martinetti F; Trompier F; Clairand I
    Phys Med; 2015 May; 31(3):248-56. PubMed ID: 25682475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility studies of a passive scatter proton therapy nozzle without a range modulator wheel.
    Harvey MC; Polf JC; Smith AR; Mohan R
    Med Phys; 2008 Jun; 35(6):2243-52. PubMed ID: 18649454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.
    Testa M; Schümann J; Lu HM; Shin J; Faddegon B; Perl J; Paganetti H
    Med Phys; 2013 Dec; 40(12):121719. PubMed ID: 24320505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility.
    Paganetti H; Jiang H; Lee SY; Kooy HM
    Med Phys; 2004 Jul; 31(7):2107-18. PubMed ID: 15305464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study.
    Bues M; Newhauser WD; Titt U; Smith AR
    Radiat Prot Dosimetry; 2005; 115(1-4):164-9. PubMed ID: 16381706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls of tungsten multileaf collimator in proton beam therapy.
    Moskvin V; Cheng CW; Das IJ
    Med Phys; 2011 Dec; 38(12):6395-406. PubMed ID: 22149823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective generation of the spread-out-Bragg peak from the laser accelerated proton beams using a carbon-proton mixed target.
    Yoo SH; Cho I; Cho S; Song Y; Jung WG; Kim DH; Shin D; Lee SB; Pae KH; Park SY
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):635-44. PubMed ID: 25154880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.